Peter J Chockley

11PUBLICATIONS

68CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 06, 2026

CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice.

|Mar 30, 2026

RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs.

Jorge Ibanez-Vega, Robert Teis, Jennifer K Ocasio

|Feb 04, 2026

Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor.

Chiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin

|Feb 02, 2026

LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen

|Aug 05, 2024

Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models.

Lindsay J Talbot, Ashley Chabot, Aaron B Ross

|Mar 14, 2023

CD47 expression is critical for CAR T-cell survival in vivo.

Alex N Beckett, Peter Chockley, Shondra M Pruett-Miller

Pageof 2

Frequent Collaborators

Giedre Krenciute

Stephen Gottschalk

Christopher DeRenzo

Charles G Mullighan

Ilaria Iacobucci

Heather Shepphard

Ashley Chabot

Alexandra Beckett

Phuong Nguyen

Paul G Thomas

Frequent Collaborators

Giedre Krenciute

Stephen Gottschalk

Christopher DeRenzo

Charles G Mullighan